Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery
Advanced Pharmaceutical Bulletin · 31.08.2025
DOI: 10.34172/apb.025.45948 ↗Kurz gefasst
Leserbrief in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 31.08.2025. Verfasst von Uppula Purushotham. Beteiligte Einrichtung: Department of Chemistry, Guru Nanak Institutions Technical Campus, School of engineering and Technology Hyderabad, Telangana, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Chemistry, Guru Nanak Institutions Technical Campus, School of engineering and Technology Hyderabad, Telangana, India.
ORCID-Profile: Uppula Purushotham
Zitieren
APA
Purushotham, U. (2025). Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery. Advanced Pharmaceutical Bulletin. https://doi.org/10.34172/apb.025.45948
Vancouver
Purushotham U. Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery. Advanced Pharmaceutical Bulletin. 2025. doi:10.34172/apb.025.45948
BibTeX
@article{Purushotham2025,
author = {Purushotham, Uppula},
title = {Enhanced Discussion on Reassessing Lipinski's Rule of Five in the Era of AI-Driven Drug Discovery},
journal = {Advanced Pharmaceutical Bulletin},
year = {2025},
doi = {10.34172/apb.025.45948}
}
EUVIMED